Latest News of CLDX
Celldex Therapeutics, Inc. (CLDX): Short Seller Sentiment is Bearish on This Cancer Stock
By Yahoo! Finance |
2 months ago
Cancer stocks are a significant sector in life sciences, with a growing burden due to various factors. Companies are developing innovative therapies, driving the market's growth to over $518 billion b...
Companies Like Celldex Therapeutics (NASDAQ:CLDX) Can Afford To Invest In Growth
By Yahoo! Finance |
3 months ago
Despite losing money, shareholders can still profit by investing in a good business at the right price. Analyzing Celldex Therapeutics' cash burn rate reveals it has a 6.8-year cash runway, with poten...